![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 09, 2021 9:58:08 PM
As for pace of dilution, yes, it is obvious some did not keep pace of dilution, well I wasn't one of them and so I am not one that is rooting for Titan to fail. You've been around for awhile, when have you ever seen Titan dilute twice in a matter of months and release absolutely nothing from a PR and the stock has more then quadrupled in PPS. You haven't, none of us have and quite honestly the ones that have kept up with dilution are thrilled with what is happening. So yes, Titan maximizing BO valuation of $6-8B is what I want now and if they accept cash money from offerings going forward at $8, $10 with minimum dilution to help position themselves for maximum BO, I am all for that. At this point in the game, OS count is irrelevent compared to potential valuation to buyer for a Novel, next generation surgical robotic platform with a tremendous IP portfolio. Any company that buys Titan's platform and get's into surgical robotics in the next 2 years will increase their companies market cap by over $15B
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM